775 related articles for article (PubMed ID: 16433886)
1. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the risk of iatrogenic hypergastrinaemia from patients with gastrinoma.
Waldum H
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):3. PubMed ID: 16433885
[No Abstract] [Full Text] [Related]
3. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
4. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
Delaney B; McColl K
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
6. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
8. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
Robinson M
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
[TBL] [Abstract][Full Text] [Related]
9. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
Hage E; Hendel L; Gustafsen J; Hendel J
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
[TBL] [Abstract][Full Text] [Related]
10. Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective.
Freston JW
Am J Gastroenterol; 1997 Apr; 92(4 Suppl):51S-55S; discussion 55S-57S. PubMed ID: 9127627
[TBL] [Abstract][Full Text] [Related]
11. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
Lamberts R
Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
[TBL] [Abstract][Full Text] [Related]
12. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
Lundell L
Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
Hirschowitz BI; Worthington J; Mohnen J; Haber M
Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471
[TBL] [Abstract][Full Text] [Related]
14. Treatment of patients with Zollinger-Ellison syndrome.
Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?
Kuipers EJ
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):187-94. PubMed ID: 16930292
[TBL] [Abstract][Full Text] [Related]
16. Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors.
Merchant SH; VanderJagt T; Lathrop S; Amin MB
Am J Surg Pathol; 2006 Dec; 30(12):1581-7. PubMed ID: 17122515
[TBL] [Abstract][Full Text] [Related]
17. Review article: the long-term use of proton-pump inhibitors.
Raghunath AS; O'Morain C; McLoughlin RC
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():55-63. PubMed ID: 16042660
[TBL] [Abstract][Full Text] [Related]
18. Review article: Strategies to determine whether hypergastrinaemia is due to Zollinger-Ellison syndrome rather than a more common benign cause.
Murugesan SV; Varro A; Pritchard DM
Aliment Pharmacol Ther; 2009 May; 29(10):1055-68. PubMed ID: 19226290
[TBL] [Abstract][Full Text] [Related]
19. Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors.
Hirschowitz BI; Worthington J; Mohnen J
Aliment Pharmacol Ther; 2008 Jun; 27(11):1110-21. PubMed ID: 18315582
[TBL] [Abstract][Full Text] [Related]
20. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]